Cytek Biosciences: Already Profitable And Fairly Valued At IPO
toondelamour/E+ via Getty Images
Quick description
Cytek Biosciences, Inc. (CTKB) is a California-based cell analysis solutions company, which set terms for an IPO (here you can find its most recent F-1 filing). In total, there are going to be 14,564,635…
